Skip to main content

Free UK delivery · Batch tested

Sermorelin — 98%+ purity research compound vial, UK stocked (HelixCore Peptides)
UK Stock

Sermorelin

Synthetic 29-amino-acid analogue of human GHRH supplied for in-vitro GHRH receptor research.

Purity

98%+ (per source specifications)

Form

Lyophilised Powder

Storage

-20°C lyophilised · store at 2–8°C once reconstituted

CAS Number

86168-78-7

Mol. Weight

3357.9 g/mol

£31.99

Free UK delivery

1
In UK stock now · Free Royal Mail Tracked 24 delivery
Free tool: Sermorelin reconstitution calculator →
Research Use Only. Sold strictly for in-vitro laboratory research. Not for human or veterinary use, medical, therapeutic or diagnostic application.
Plain packaging suitable for laboratory deliveries.

About Sermorelin

What it is

Sermorelin is GHRH(1-29) — the first twenty-nine amino acids of growth-hormone-releasing hormone, which is the shortest fragment retaining full biological activity of the parent hormone. It was formerly marketed as a medicine under the name Geref, since discontinued.

How it is understood to work

It binds the GHRH receptor on pituitary somatotrophs. Because it acts on the pituitary rather than supplying growth hormone directly, release remains subject to the body's own regulation, including negative feedback through somatostatin. That preserved feedback is a large part of why the fragment is used as a research tool.

What research has looked at

Pituitary function testing, endocrine research on the GH axis, and comparative work against modified analogues such as CJC-1295, which were developed specifically to overcome its very short half-life.

Handling and storage

Short-lived in solution relative to the modified analogues. Reconstitute what is needed, keep refrigerated, and do not expect extended stability.

Supplied for in-vitro laboratory research only. Nothing above describes a dose, a protocol, or a use in humans or animals, and none of these compounds is a licensed medicine in the UK.

Research Information

Sermorelin is a synthetic 29-amino-acid peptide representing the active N-terminal fragment of human growth-hormone releasing hormone (GHRH 1-29). It's studied for its role in GHRH receptor research. Because it's effectively the minimal active GHRH sequence, researchers use it as a reference compound for studying receptor binding and signalling without the rest of the native 44-amino-acid GHRH molecule. Most published work has used pituitary cell models to examine binding affinity and downstream cyclic AMP signalling.

Research areas

  • GHRH receptor binding affinity studies
  • Pituitary cell-line research
  • Minimal-active-sequence reference studies
  • Cyclic AMP signalling pathway research

Analytical methods

Identity and purity are typically confirmed at source by high-performance liquid chromatography (HPLC) and mass spectrometry.

Storage and handling

Store lyophilised at -20°C, away from moisture and direct light. Once reconstituted, store at 2–8°C and use within the timeframe specified on the source datasheet.

For Research Use Only. Not for human or veterinary use.

Batch tested

Every batch is tested for identity and purity, and we publish the certificate.

UK dispatch

UK-stocked. Orders placed before 2pm dispatch the same business day via Royal Mail Tracked 24. Free UK shipping on every order. We ship to UK addresses only.

Frequently asked questions